Pancreatic Cancer Research

ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Joanna Napp

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9034-9980; OpenAlex author ID A5005836968. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 4

  1. Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic tra… Co-author DOI 10.3389/fonc.2024.1454291↗
  2. High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic Cancer. Co-author DOI 10.1002/adma.202305151↗
  3. Crosstalk between tumor acidosis, p53 and extracellular matrix regulates pancreatic cancer aggressiveness. Co-author DOI 10.1002/ijc.34367↗
  4. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells. Co-author DOI 10.1002/ijc.30380↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Frauke Alves · 4 shared papers, 2016–2024 · strength 0.66
  2. Silke Cameron · 1 shared paper, 2024 · strength 0.23
  3. Volker Ellenrieder · 1 shared paper, 2024 · strength 0.23
  4. Myrto Ischyropoulou · 1 shared paper, 2023 · strength 0.20
  5. Dominika Czaplińska · 1 shared paper, 2023 · strength 0.15
  6. Henriette Berg Andersen · 1 shared paper, 2023 · strength 0.15
  7. Arnaud Stigliani · 1 shared paper, 2023 · strength 0.15
  8. Renata Ialchina · 1 shared paper, 2023 · strength 0.15
  9. Mette Flinck · 1 shared paper, 2023 · strength 0.15
  10. Stine F. Pedersen · 1 shared paper, 2023 · strength 0.15
  11. Albin Sandelin · 1 shared paper, 2023 · strength 0.15
  12. Andrea Giannuzzo · 1 shared paper, 2016 · strength 0.07
  13. Ivana Novak · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.